FDA Investigator Saleem A Akhtar

Saleem A Akhtar has inspections in 15 countries as of 18 Oct 2023. Saleem A Akhtar has collaborated with a combinined 7163 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
87
Last Inspection Date:
18 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Greece, India, Turkey, Germany, Switzerland, United Kingdom of Great Britain and Northern Ireland, France, China, Japan, Ireland, Italy, Israel, Austria
Co-Investigator(s):
Abby Lmozeke Baker, Adaris Mas Rivera, Ademola O Daramola, Adetutu M Gidado, Aditi S Thakur, Adrian Rodriguez, Alan P Kurtzberg, Alberto A Viciedo, Alice S Tsao, Allen Lou, Amy C Jordan, Amy L Singer, Amy M Cramer, Amy N Chen, Anastasia I Offordile, Anastasia M Shields, Angela E Glenn, Angela Mock, Anh M Lac, Anita Narula, PhD, Anita R Michael, Ankur C Patel, Annemarie Bodnar, Annet R Rajan, Anthony A Charity, Anthony C Warchut, Anthony J Donato, Anya D Lockett Evans, Arsen Karapetyan, Atul J Agrawal, Azza Talaat, Bapu R Gaddam, Barbara A Rusin, Barbara I Rogolsky, Barbara J Maulfair, Barbara J Wilimczyk, Barbara Janine Breithaupt, Barbara Jwilimczyk Macri, Barbara L Rogolsky, Bijoy Panicker, Bing Lin, Blondell W Johnson, Bonita S Chester, Brian D Nicholson, Brooke K Higgins, Brooke K Seeman, Carl A Huffman, III, Carla A Norris, Carla J Lundi, CDR Ileana Barreto Pettit, Charles D Brown, Charles M Edwards, Charles R Cote, RIC, Charles Yuanchia Kuo, PhD, Chelsea N Sealey, Cheryl A Clausen, Christie A Soto, Christina N Maurino, Christopher D Leach, Christopher N Tran, Christopher R Czajka, Christopher S Keating, Christopher T Middendorf, Christos G Tsingelis, Cody D Rickman, Concepcion Cruz, Jr, Constantin Y Philopoulos, Courtney A Gilbert, Courtney N Long, Cynthia A Palmer, Cynthia M Goudeau, Daniel J Lahar, Daniel J Min, Daniel J Roberts, Darren S Brown, Daryl A Dewoskin, David A Oluwo, David M Beltran, Dawn L Wydner, Denise M Digiulio, Devaugh Edwards, Devaughn Edwards, Deyaa Shaheen, Dipesh K Shah, Doan T Nguyen, PharmD, Don H Bark, PhD, Donald L Lech, Dongping Dai, PhD, Douglas A Campbell, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Dominick Roselle, Dusty F Snoeberg, Edmund F Mrak, Jr, Edward H Maticka, Edward Oshaughnessy, Edwin Ramos, Elkins, Emest F Bizjak, Emmanuel J Ramos, Eric M Mueller, PharmD, Eric Rothschild, Erik W Koester, Erika V Butler, Erin D Mccaffery, Ernest Serna, III, Farhana Khan, Felix Maldonado, Francis A Guidry, Frank J Marciniak, Freddy Ortiz Colon, Frederick Razzack, Frederick Razzaghi, Gale L Glinecki, Gam S Zamil, Garry H Stewart, Gayle S Lawson, Geraldine D Sanders, Gianine E Delade, Gianine E Tompkins, Ginger M Sykes, Guerlain Ulysse, Gwyn G Dickinson, Hala L Selby, Hala Lj Whetstone, Harry J Brewer, Hasan A Irier, PhD, Helen B Ricalde, Helen Verdel, Heriberto Negron Rivera, Himanshu Gupta, PhD, Israel Santiago, OCM, Ivan E Reyes, Ivis Lnegron Torres, James C Maclaughlin, James I Giefer, James M Mason, James S Cartwright, James W Whitney, Jamie M Bumpas, Janet A Rajan, Javier O Vega, Jawaid Hamid, Jeanne Fringer, PhD, Jeffery A Hangartner, Jeffrey A Sommers, Jennifer A Robinson, Jennifer Lalama, Jennifer M Gogley, Jeremy W Rotton, Jessica L Pressley, Jessica S Estriplet, Jill J Tillman, Joanne E King, Jogy George, John S Hartford, Jonah S Ufferfilge, Jonathan W Chapman, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose M Cayuela, Jose Martinez, Jr, Jose O Hernandez, Jose Ohernandez Guzman, Jose Perez Soto, Jose R Hernandez, Joseph R Lambert, Joshua J Silvestri, Joy Rkozlowski Klena, Julianne C Mccullough, June P Page, Junho Pak, Justin A Boyd, Karen A Briggs, Karen C Daugherty, Karen E D'orazio, Karishma G Gopaul, Karl D Hezel, Karlton T Watson, Katherine E Jacobitz, Katherine Szestypalow, Kathleen M Jordan, Kejun Cheng, Kellia N Hicks, Kelly Doremus, Kendra L Brooks, Kenneth H Williams, Kevin D Kallander, Kham Phommachanh, Kim Lthomas Cruse, Ko U Min, Kristina L Conroy, Kristy A Zielny, Laishan L Lam, Lance M De Souza, MBA, Larry K Austin, Lata C Mathew, PhD, Lauren L Vajo, Laurimer Kuilan Torres, Lawrence C Coleman, Lawrence R Johnson, LCDR Chad N Thompson, LCDR Debra Emerson, LCDR Michael H Tollon, Leiyun Boone, PhD, Leonard H Lavi, Li Li, Liatte Kreuger, PharmD, Liming Zhang, Linda F Murphy, Linda L Ng, Linda M Hoover, Lindsey M Schwierjohann, Lisa L Flores, Lisa M Bellows, Lisa R Jennings, Lourdes Andujar, Lourdes R Genera, LT Kimberly M Hull, Lucas B Leake, Luis A Dasta, Luis M Burgos Medero, Lynne Ensor, Makini Cobourne Duval, PhD, Mamta Gautam Basak, PhD, Marcellinus D Dordunoo, Marcus A Ray, Margaret M Annes, Maria Estrella, Marianela Aponte Cruz, Marie Bbuen Bigornia, Marie F Morin, Mark C Saale, Marlene G Swider, Martha S Baldwin, Martrice A Packer, Massoud Motamed, Matthew B Casale, Matthew M Henciak, Matthew R Dionne, Matthew R Maddox, Meena Bansal Gupta, PhD, Megan A Haggerty, Melissa B Libby, Melissa J Garcia, Melissa T Roy, Michael A Charles, Michael L Casner, Michael L Chasey, Michael R Goga, Michael R Klapal, Michele Gottshall, Michele L Obert, Michelle J Glembin, Michelle S Dunaway, Miguel A Martinez, Minh D Phan, Monica Cburgos Garcia, Monika Borkowska, Moraima J Ramos Valle, Mra Mcculloughj, Mra Munizn, Mra Narulaa, Muralidhara B Gavini, PhD, Nailing Zhang, Nancy F Scheraga, Nancy G Schmidt, Nancy M Espinal, Nancy Sheraga, Nayan J Patel, Nebil A Oumer, Nicholas A Violand, Nicole E Knowlton, Noreen Muniz, Oluwasefunm Agbanigo, Pankaj H Amin, Parul M Patel, Patricia Fhughes Troost, Patricia H Dlugosz, Patrick C Klotzbuecher, Patty P Kaewussdangkul, Paul A Bonneau, Paul L Bellamy, Paul L Figarole, Jr, Paul Mouris, Paula J Bretz, Peter E Baker, Peter R Lenahan, Prabhu P Raju, Pratibha Bhat, Pratik S Upadhyay, DDC, Qin Xu, Rachael O Oyewole, Rajiv R Srivastava, Ralph A Erickson, Ralph H Vocque, Raymond T Oji, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Robert D Tollefsen, Robert J Martin, Robin P Mathew, Rodney L Tinzie, Roger F Zabinski, Rosario D'costa, Roy Baby, Roy R Rinc, Rozelle G Smith, Russ E Davis, Russell J Glapion, Ruth Moore, PhD, S Lori Brown, PhD MPH, Sachinkumar V Patel, Sakineh Walther, Salvatore N Randazzo, Sam Pepe, Samantha J Bradley, Samuel A Hamblin, Samuel Mindaye, Sandra A Boyd, Sandra A Hughes, Sangeeta M Khurana, PhD, Santos E Camara, Sarah Ibrahim, Satheesh Thomas, Schultz, Scott B Laufenberg, Scott R Nichols, PhD, Scott T Ballard, Sean R Marcsisin, Sena G Dissmeyer, Seneca D Toms, Shavon L Square, Shelby N Marler, Sheri L Stephenson, Sherri J Liu, Sherrie L Krolczyk, Shirley J Berryman, Shirley S Wen, Simone E Pitts, Sixto M Mercado Rios, Sneha S Patel, Srinivas R Chennamaneni, PhD, Stacey S Degarmo, State Agency, Stelios C Tsinontides, Stephanie D Crockett, Stephen D Brown, Stephen J Koniers, Stephen J Mottola, Stephen L Beekman, Steven A Gonzales, Steven D Kehoe, Steven Fong, MS, PhD, Steven M Weinman, Susan M Turcovski, Tamera H Hunt, Tamil Arasu, PhD, Tara A Gray, Tara G Bizjak, Tara L Greene, Ted L Anderson, Temar Q Williams, Terri L Dodds, Thomas J Arista, Thomas R Withers, Thuy T Nguyen, LCDR, Tiffani D Wilson, Tonia F Bernard, Torrance J Slayton, Tricia S Martinez, Truong Xuan Nguyen (Andy), Uduak M Inokon, Unnee Ranjan, Uttaniti Limchumroon (Tom), Valerie C Reed, Vani Mathur Richards, Vilmary Negron Rodriguez, Vlada Matusovsky, Walden H Lee, Wayne E Seifert, Wayne J Meyer, Wenzheng Zhang, William A Warnick, William J Leonard, William R Chang, Xiaohan Cai, PhD, Xiaokuang Lai, PhD, Yan Wang, Yasamin Ameri, Youmin Wang, Yvesna C Blaise, Yvins Dezan, Zachary L Stamm, Zedong Dong, Zhaoyang Meng, Zhihao Qiu (Peter), PhD

Saleem A Akhtar's Documents

Publish Date Document Type Title
February, 2019 EIR DEVA HOLDING ANONIM SIRKETI - CERKEZKOY 2 URETIM TESISI SUBESI - EIR, 2019-02-15
January, 2016 EIR Sovereign Pharmaceuticals, LLC - EIR, 2016-01-08
April, 2016 FDA 483 Otsuka Pharmaceutical Co Ltd - Form 483, 2016-04-15
October, 2023 FDA 483 NATCO PHARMA LIMITED - Form 483, 2023-10-18
December, 2018 FDA 483 MYLAN LABORATORIES LIMITED - Form 483, 2018-12-10
December, 2016 FDA 483 CIPLA LIMITED - Form 483, 2016-12-09
November, 2020 FDA 483 Response Novel Laboratories, Inc. - Form 483R, 2020-11-05
May, 2022 FDA 483 Sun Pharmaceutical Industries Limited - Form 483, 2022-05-09
May, 2021 FDA 483 HOVIONE LLC - Form 483, 2021-05-28
July, 2015 EIR ImClone Systems LLC - EIR, 2015-07-10
December, 2018 FDA 483 APL HEALTHCARE LIMITED - Form 483, 2018-12-21
November, 2015 FDA 483 Response Horizon Pharmaceuticals , Inc. - Form 483R, 2015-11-28
March, 2019 FDA 483 Biochem Laboratory, Inc - Form 483, 2019-03-26
June, 2023 FDA 483 Ipca Laboratories Limited - Form 483, 2023-06-23
June, 2023 FDA 483 Ipca Laboratories Limited - Form 483, 2023-06-13
December, 2019 EIR PHARMATHEN INTERNATIONAL S.A. - EIR, 2019-12-06
November, 2020 FDA 483 Novel Laboratories, Inc. - Form 483, 2020-11-05
December, 2019 FDA 483 PHARMATHEN INTERNATIONAL S.A. - Form 483, 2019-12-06
May, 2021 FDA 483 Response HOVIONE LLC - Form 483R, 2022-02-18
April, 2016 FDA 483 Otsuka Pharmaceutical Co., Ltd. - Form 483, 2016-04-08
September, 2021 FDA 483 Response Tender Corporation - Form 483R, 2021-10-15
August, 2017 FDA 483 AIZANT DRUG RESEARCH SOLUTIONS PVT LTD - Form 483, 2017-08-18
June, 2015 EIR Amazon Forest, Inc. - EIR, 2015-06-17
September, 2021 FDA 483 Tender Corporation - Form 483, 2021-09-23
February, 2018 FDA 483 Mylan Teoranta - Form 483, 2018-02-16
December, 2018 FDA 483 Jubilant Pharmova Limited - Form 483, 2018-12-18
January, 2017 FDA 483 NIPPON FINE CHEMICAL CO.,LTD - Form 483, 2017-01-31
March, 2022 FDA 483 Zydus Lifesciences Limited - Form 483, 2022-03-10
October, 2017 FDA 483 Jubilant Pharmova Limited - Form 483, 2017-10-27
March, 2016 FDA 483 Response Catalent Pharma Solutions, LLC - Form 483R, 2016-04-15
June, 2016 EIR Loba biotech GmbH - EIR, 2016-06-24
April, 2017 FDA 483 Eugia Pharma Specialities Limited - Form 483, 2017-04-28
April, 2022 FDA 483 Par Formulations Private Limited - Form 483, 2022-04-05
July, 2022 FDA 483 KVK-TECH, INC. - Form 483, 2022-07-12
February, 2019 FDA 483 DEVA HOLDING ANONIM SIRKETI - CERKEZKOY 2 URETIM TESISI SUBESI - Form 483, 2019-02-15
February, 2019 FDA 483 Response DEVA HOLDING ANONIM SIRKETI - CERKEZKOY 2 URETIM TESISI SUBESI - Form 483R, 2019-03-06
November, 2015 FDA 483 Horizon Pharmaceuticals , Inc. - Form 483, 2015-11-05
May, 2018 FDA 483 Shouguang Fukang Pharmaceutical Co., Ltd. - Form 483, 2018-05-25
December, 2018 EIR Jubilant Pharmova Limited - EIR, 2018-12-18
March, 2016 FDA 483 Catalent Pharma Solutions, LLC - Form 483, 2016-03-25
November, 2022 FDA 483 USV Private Limited - Form 483, 2022-11-17
January, 2016 FDA 483 Sovereign Pharmaceuticals, LLC - Form 483, 2016-01-08
October, 2021 FDA 483 Afton Scientific, LLC - Form 483, 2021-10-22
April, 2017 FDA 483 Mylan Laboratories Limited - Form 483, 2017-04-18
August, 2020 FDA 483 AACE PHARMACEUTICALS, INC. - Form 483, 2020-08-10
February, 2023 FDA 483 CIPLA LIMITED - Form 483, 2023-02-17
September, 2022 FDA 483 Symbiotec Pharmalab Private Limited - Form 483, 2022-09-30
July, 2018 EIR Reed-Lane, Inc. - EIR, 2018-07-25
September, 2019 FDA 483 Alchem International Private Ltd - Form 483, 2019-09-06
December, 2023 FDA 483 DR. REDDY'S LABORATORIES LIMITED - Form 483, 2023-12-08
December, 2023 FDA 483 DR. REDDY'S LABORATORIES LIMITED - Form 483, 2023-12-08
December, 2023 FDA 483 DR. REDDY'S LABORATORIES LIMITED - Form 483, 2023-12-08

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more